Information Box Group
This page allows users to read and learn about the topics and items included in the GIN-McMaster Guideline Development Checklist (GDC) as well as to provide feedback and suggestions. The GDC is organized into 18 topics for the guideline development process, with corresponding items to consider for each topic. Users of the checklist should review all topics and items before applying them as they are not necessarily sequential and many are interconnected.
The overall guideline development process is outlined in the diagram below, which portrays the relationships between the various topics in guideline development and the groups involved. Please also see the online glossary for definitions of terms and acronyms appearing throughout the checklist.
Where identified, the checklist includes links to learning tools, articles and guides to learn about the items in the checklist. Also included are resources and tools with suggested methodology for implementing the items that developers may use to in their guideline development. The brief examples that are included in some items are for clarification and elaboration and are not meant to be extensive instructions for how to accomplish the steps.
We would like to obtain feedback so that the checklist may be updated in the future based on the experience of users. Please click the ‘feedback’ link beside the topic or item, which will open up an email message for users to submit comments and suggestions for existing items, new items or topics, learning tools, and resources for implementation.
Clicking on the links in the list of guideline development topics below will bring you to that specific section in the checklist. Clicking again on the topic title in the checklist will bring you back to the list of topics.
Guideline Development Topics:
- Organization, Budget, Planning and Training
- Priority Setting
- Guideline Group Membership
- Establishing Guideline Group Processes
- Identifying Target Audience and Topic Selection
- Consumer and Stakeholder Involvement
- Conflict of Interest Considerations
- (PICO) Question Generation
- Considering Importance of Outcomes and Interventions, Values, Preferences and Utilities
- Deciding what Evidence to Include and Searching for Evidence
- Summarizing Evidence and Considering Additional Information
- Judging Quality, Strength or Certainty of a Body of Evidence
- Developing Recommendations and Determining their Strength
- Wording of Recommendations and of Considerations of Implementation, Feasibility and Equity
- Reporting and Peer Review
- Dissemination and Implementation
- Evaluation and Use
- Updating
Guideline Development Process Diagram:
Checklist:
Guideline Development |
Source(s) |
Learning Guides, |
Resources |
Feedback (Click |
1. |
PATS:
|
|
||
2. |
|
|
||
3. |
|
|
||
4. |
AWMF Rules for
Dutch Knowledge |
|
||
5. |
|
|
||
6. |
AWMF Rules for
|
|
||
7. |
|
|||
8. |
|
|
||
9. |
|
Dutch Knowledge |
||
10. |
|
|
||
11. |
WHO
Allergic Rhinitis
ACCP |
AWMF Rules for Guidelines:
Dutch Knowledge |
||
1. Decide on a process for priority setting of guideline topics needed and who will be |
|
Institute
SUPPORT Tools for
|
|
|
2. Apply a systematic and transparent process with specific criteria for the proposal of a guideline topic during priority setting (e.g. high prevalence and burden of disease, avoidable mortality and morbidity, high cost, emerging diseases or emerging care options, variation in clinical practice, rapidly changing |
SIGN: Topic
AWMF Rules for
|
Dutch Knowledge |
||
3. Involve appropriate stakeholders in the priority setting process and guideline topic selection (e.g. clinicians, professional societies, policymakers, payers, the public). (see Topic 6) |
|
|
||
4. Consider and decide how different perspectives about the importance and resources required for implementing the guideline recommendations will be considered (e.g. patients, payers, clinicians, public health programs). (see Topic 11) |
|
|
||
5. Search for any existing up-to-date guidelines covering the proposed topic and assess their credibility (e.g. AGREE II). Determine whether existing guideline(s) can be adapted or if a completely new guideline should be developed. (see also Topic 10) |
|
Clinical Practice Guidelines Literature Search Strategy
AWMF Rules for
|
||
6. Discuss the need or opportunity to partner with other organizations that develop guidelines to |
|
|||
7. Perform a scoping exercise for the proposed guideline topic with respect to implementation issues and barriers to change (e.g. if developed the guideline |
|
|
||
8. Select or provide a consensus method to be used to agree on the priorities set and the guideline topic selected (e.g. voting, Delphi consensus). (see Topic 4). |
|
|
||
9. Document the priority setting process and guideline topic selected to ensure transparency. |
|
|||
1. |
PATS:
AWMF Rules for |
AWMF Letter |
||
2. |
|
|
||
3. |
Pagliari |
|
||
4. |
|
|||
5. |
|
|||
6. |
|
|
||
7. |
ACCP |
|
||
1. |
AWMF Rules for |
|||
2. |
|
|||
3. |
|
|
||
4. |
|
|
||
5. |
||||
6. |
E*, 6 |
|
|
|
7. |
|
|
||
8. |
|
|
||
9. |
|
|
||
10. |
|
|
||
1. |
|
|||
2. |
|
|
||
3. |
|
|
||
4. |
|
|
||
5. |
|
|
||
6. Document the processes of identifying the target audience(s) and selection of topics for the guideline to ensure transparency.
|
|
|
||
1. |
NICE |
|
||
2. |
NICE
|
|
||
3. |
|
|
||
4. |
|
|
||
5. |
PATS:
|
|
||
6. |
|
|
||
7. |
|
|
||
8. |
|
|
||
9. |
|
|
||
1. |
NICE
NMHRC
AWMF Rules for
|
NHMRC:
AWMF Disclosure |
||
2. |
|
|
||
3. |
|
|
||
4. |
|
|||
5. |
|
|||
6. |
|
|
||
7. |
|
|||
1. |
JCE
AWMF Rules for (in
|
|
||
2. |
|
PICO
|
||
3. |
PATS: |
|
||
4. |
|
|
||
5. |
|
|
||
6. |
|
|
||
7. |
|
|
||
8. |
JCE |
|
||
9. |
JCE |
|
||
10. |
|
|
||
11. |
|
|
||
12. |
|
|
||
13. |
|
|
||
9. Considering Importance of Outcomes and Interventions, Values, Preferences and Utilities |
||||
1. |
|
|
||
2. Establish methods for consultation with consumers and stakeholders to obtain information about the relative importance of outcomes and interventions, |
PATS:
|
|
||
3. Determine if a structured approach for assessing the confidence in the obtained importance ratings, values, preferences and utilities (i.e. quality of the evidence in them) will be used. |
E, 49 |
|
|
|
4. Determine if modelling will be used to integrate the relative importance of outcomes and interventions, values, preferences or utilities and how modelling will be done. |
|
|
||
5. Determine whose perspective(s) will be considered when obtaining information about the relative importance of outcomes and interventions, values, preferences or utilities and when making decisions or formulating recommendations (e.g. patients, public, society, clinicians). |
|
|
||
6. |
|
|
||
7. |
|
|
||
8. |
|
|
||
9. |
|
|
||
10. Deciding what Evidence to Include and Searching for Evidence |
||||
1. |
Cochrane Handbook
Cochrane |
|
||
2. |
AWMF Rules for |
AWMF Manual for
AMSTAR: Checklist
SIGN
|
||
3. |
|
|
||
4. |
|
|
||
5. |
|
|
||
6. |
|
|
||
7. |
|
|
||
8. |
|
|
||
9. |
|
|
||
10. |
|
|
||
11. Summarizing Evidence and Considering Additional Information |
||||
1. |
JCE |
|
||
2. |
SUPPORT Tools for
HRPS:
NICE |
|
||
3. |
HRPS: |
Dutch Knowledge |
||
4. |
|
|
||
5. |
|
|
||
6. |
|
|
||
7. |
|
|
||
12. Judging Quality, Strength or Certainty of a Body of Evidence |
||||
1. |
|
|||
2. |
|
|
||
3. |
|
|
||
4. |
|
|
||
5. |
|
|
||
6. |
|
|
||
13. Developing Recommendations and Determining their Strength |
||||
1. |
JCE
PATS: |
|
||
2. |
|
|
||
3. |
|
|
||
4. |
|
|
||
5. |
PATS: |
Dutch Knowledge |
||
6. |
JCE
PATS: |
|
||
7. |
AWMF Rules for |
|||
8. |
AWMF Summary of |
|
||
9. |
|
|
||
10. |
|
|
||
14. Wording of Recommendations and of Considerations of Implementation, Feasibility and Equity |
||||
1. |
Shiffman,
PATS:
AWMF Rules for |
|
||
2. |
|
|||
3. |
|
|||
4. |
|
|
||
5. |
HRPS:
|
|
||
6. |
|
|
||
7. |
|
|
||
8. |
|
|
||
1. |
Shiffman,
AWMF Guide to |
|||
2. |
AWMF Rules for |
|
||
3. |
|
|
||
4. |
|
|
||
5. |
AWMF Rules for |
|
||
6. |
|
|
||
7. |
AWMF Rules for |
|
||
8. |
|
|
||
1. |
AWMF Rules for
HRPS:
|
Dutch Knowledge
Dutch Knowledge Base |
||
2. |
|
|||
3. |
|
|
||
4. |
European |
|
||
1. |
E, 66 |
|
||
2. |
|
|||
3. |
AWMF Rules for |
Dutch Knowledge |
||
4. |
|
|
||
5. |
|
|
||
6. |
|
|
||
1. |
AWMF Rules for |
|
||
2. |
|
|
||
3. |
|
|
||
4. |
|
|
||
5. |
|
|
||
6. |
Cancer |
|
*E – Item
informed by expert consultation
References:
- Fretheim A, Schunemann H, Oxman A. Improving the use of research evidence in guideline development: 3. Group composition and consultation process.Health Research Policy and Systems. 2006;4(1):15.
- Kunz R, Fretheim A, Cluzeau F, et al. Guideline Group Composition and Group Processes: Article 3 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):229-233.
- The ADAPTE Collaboration. The ADAPTE Process: Resource Toolkit for Guideline Adaptation. Version 2.0. 2009;http://www.g-i-n.net/document-store/working-groups-documents/adaptation/adapte-resource-toolkit-guideline-adaptation-2-0.pdf. Accessed July 5, 2013.
- World Health Organization. Estonian Handbook for Guidelines Development. 2011;http://whqlibdoc.who.int/publications/2011/9789241502429_eng.pdf. Accessed April 22, 2013.
- National Institute for Health and Clinical Excellence. The guidelines manual. 2012;http://www.nice.org.uk/article/PMG6/chapter/1%20Introduction. Accessed April 22, 2013.
- Scottish Intercollegiate Guidelines Network. SIGN 50: A guideline developer’s handbook. 2011;http://www.sign.ac.uk/guidelines/fulltext/50/. Accessed April 22, 2013.
- World Health Organization. WHO Handbook for Guideline Development. 2012;http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf. Accessed April 22, 2013.
- American College of Cardiology Foundation and American Heart Association. Methodology Manual and Policies from the ACCF/AHA Task Force on Practice Guidelines. 2010;http://my.americanheart.org/professional/StatementsGuidelines/PoliciesDevelopment/Development/Methodologies-and-Policies-from-the-ACCAHA-Task-Force-on-Practice-Guidelines_UCM_320470_Article.jsp. Accessed April 22, 2013.
- Rosenfeld RM, Shiffman RN, Robertson P. Clinical Practice Guideline Development Manual, Third Edition: A Quality-Driven Approach for Translating Evidence into Action.Otolaryngology — Head and Neck Surgery. 2013;148(1 suppl):S1-S55.
- Cancer Care Ontario. Program in Evidence-Based Care Handbook. 2012;http://www.cancercare.on.ca/about/programs/pebc/pebc-products/. Accessed April 22, 2013.
- Centers for Disease Control and Prevention.Guidelines and Recommendations: A CDC Primer. Atlanta, Georgia: Office of the Associate Director for Science Centers for Disease Control and Prevention;2012.
- Davino-Ramaya C, Krause LK, Robbins CW, et al. Transparency matters: Kaiser Permanente’s National Guideline Program methodological processes.The Permanente journal. Winter 2012;16(1):55-62.
- Canadian Task Force on Preventive Health Care. Canadian Task Force on Preventive Health Care Procedure Manual. 2011;http://canadiantaskforce.ca/methods/methods-manual/. Accessed April 22, 2013.
- Gutierrez GC, Bossert T, Espinosa JQ, et al. Guia Metodologica para la elaboracion de Guias de Atencion Integral en el Sistema General de Seguridad Social en Salud Colombiano. 2010;http://www.minsalud.gov.co/Documentos%20y%20Publicaciones/GUIA%20METODOLOGICA%20PARA%20LA%20ELABORACI%C3%93N%20DE%20GU%C3%8DAS%20DE%20ATENCI%C3%93N%20INTEGRAL.pdf. Accessed April 22, 2013.
- Ministerio de Sanidad y Consumo. Elaboracion de guias de practica clinica en el sistema nacional de salud: Manual metodologico. 2007;http://www.guiasalud.es/emanuales/elaboracion/index-02.html. Accessed April 22, 2013.
- German Association of the Scientific Medical Societies (AWMF) – Standing Guidelines Commission. AWMF Guidance Manual and Rules for Guideline Development, 1st Edition, English Version. 2012;http://www.awmf.org/leitlinien/awmf-regelwerk/awmf-guidance.html. Accessed May 2, 2014.
- Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development: 2. Priority setting.Health Research Policy and Systems. 2006;4(1):14.
- American College of Cardiology Foundation and American Heart Association. Manuscript Development Process. 2010;http://my.americanheart.org/professional/StatementsGuidelines/PoliciesDevelopment/Policies-Development_UCM_316897_Article.jsp. Accessed April 22, 2013.
- New Zealand Guidelines Group.Handbook for the preparation of explicit evidence-based clinical practice guidelines. Wellington: New Zealand Guidelines Group;2001.
- Agency for Healthcare Research and Quality. U.S. Preventive Services Task Force Procedure Manual. 2008;http://www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual.htm. Accessed April 22, 2013.
- National Health and Medical Research Council. Procedures and requirements for meeting the 2011 NHMRC standard for clinical practice guidelines. 2011;http://www.nhmrc.gov.au/guidelines/publications/cp133-and-cp133a. Accessed April 22, 2013.
- Ministerio de Salud. Norma tecnica para la elaboracion de guias de practica clinica. 2005;http://bvs.minsa.gob.pe/local/MINSA/1176_DGSP196.pdf. Accessed April 22, 2013.
- Qaseem A, Forland F, Macbeth F, Ollenschlager G, Phillips S, van der Wees P. Guidelines International Network: Toward international standards for clinical practice guidelines.Ann Intern Med. 2012;156(7):525-531.
- Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust. 2011;http://www.nap.edu/openbook.php?record_id=13058. Accessed April 22, 2013.
- European Society of Cardiology. Recommendations for Guidelines Production. 2010;http://www.escardio.org/guidelines-surveys/esc-guidelines/about/Pages/rules-writing.aspx. Accessed April 22, 2013.
- Boyd EA, Akl EA, Baumann M, et al. Guideline Funding and Conflicts of Interest: Article 4 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):234-242.
- Brouwers MC, Kho ME, Browman GP, et al. AGREE II: Advancing guideline development, reporting and evaluation in health care.Canadian Medical Association Journal. 2010;182(18):E839-E842.
- Schunemann H, Fretheim A, Oxman A. Improving the use of research evidence in guideline development: 1. Guidelines for guidelines.Health Research Policy and Systems. 2006;4(1):13.
- National Institute for Health and Clinical Excellence. How NICE clinical guidelines are developed: An overview for stakeholders, the public and the NHS. 5th Edition. 2012;http://publications.nice.org.uk/pmg6f. Accessed April 22, 2013.
- Jacobs AK, Kushner FG, Ettinger SM, et al. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol. 2013;61(2):213-265.
- Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity.Health Research Policy and Systems. 2006;4(1):24.
- Cluzeau F, Wedzicha JA, Kelson M, et al. Stakeholder Involvement: How to Do It Right: Article 9 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):269-273.
- Fretheim A, Schunemann H, Oxman A. Improving the use of research evidence in guideline development: 5. Group processes.Health Research Policy and Systems. 2006;4(1):17.
- Wilt TJ, Guyatt G, Kunz R, et al. Deciding What Type of Evidence and Outcomes to Include in Guidelines: Article 5 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):243-250.
- Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization.Ann Intern Med. 2003;139(6):493-498.
- Atkins D, Perez-Padilla R, MacNee W, Buist AS, Cruz AA. Priority Setting in Guideline Development: Article 2 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):225-228.
- Eccles M, Grimshaw J, Shekelle P, Schunemann H, Woolf S. Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest.Implementation Science. 2012;7(1):60.
- Akl EA, Treweek S, Foy R, Francis J, Oxman AD, Re Bg. NorthStar, a support tool for the design and evaluation of quality improvement interventions in healthcare.Implement Sci. 2007;2:19.
- Burgers JS, Anzueto A, Black PN, et al. Adaptation, Evaluation, and Updating of Guidelines: Article 14 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):304-310.
- Esandi ME, Luca MD, Chapman E, Schapochnik N, Bernztein R, Otheguy L. Guia para la adaptacion de Guoas de Practica Clinica. 2008;http://publicaciones.ops.org.ar/publicaciones/otras%20pub/GuiadeGuias.pdf. Accessed April 22, 2013.
- Schunemann HJ, Woodhead M, Anzueto A, et al. A guide to guidelines for professional societies and other developers of recommendations: Introduction to integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.Proceedings of the American Thoracic Society. 2012;9(5):215-218.
- Shekelle P, Woolf S, Grimshaw J, Schunemann H, Eccles M. Developing clinical practice guidelines: reviewing, reporting, and publishing guidelines; updating guidelines; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development.Implementation Science. 2012;7(1):62.
- Yawn BP, Akl EA, Qaseem A, Black P, Campos-Outcalt D. Identifying Target Audiences: Who Are the Guidelines For?: Article 1 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):219-224.
- Guyatt GH, Norris SL, Schulman S, et al. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest. 2012;141(2 Suppl):53S-70S.
- National Institute for Health and Clinical Excellence. The guidelines manual: Appendix A – Agreements and advice for Guideline Development Group members. 2012;http://publications.nice.org.uk/pmg6a. Accessed April 22, 2013.
- National Health and Medical Research Council. Guideline Development and Conflicts of Interest: Identifying and Managing Conflicts of Interest of Prospective Members and Members of NHMRC Committees and Working Groups Developing Guidelines. 2012;http://www.nhmrc.gov.au/guidelines-and-publications/information-guideline-developers/guideline-development-and-conflicts. Accessed April 22, 2013.
- Woolf S, Schunemann H, Eccles M, Grimshaw J, Shekelle P. Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations.Implementation Science. 2012;7(1):61.
- Kelson M, Akl EA, Bastian H, et al. Integrating Values and Consumer Involvement in Guidelines with the Patient at the Center: Article 8 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):262-268.
- Schunemann H, Fretheim A, Oxman A. Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement.Health Research Policy and Systems. 2006;4(1):22.
- Boyd E, Bero L. Improving the use of research evidence in guideline development: 4. Managing conflicts of interests.Health Research Policy and Systems. 2006;4(1):16.
- Cancer Care Ontario. Program in Evidence-Based Care Conflict of Interest Policy. 2011;http://www.cancercare.on.ca/cms/one.aspx?objectId=7582&contextId=1377. Accessed April 22, 2013.
- Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development: 14. Reporting guidelines.Health Research Policy and Systems. 2006;4(1):26.
- Schunemann H, Oxman A, Fretheim A. Improving the use of research evidence in guideline development: 6. Determining which outcomes are important.Health Research Policy and Systems. 2006;4(1):18.
- Fabbri LM, Boyd C, Boschetto P, et al. How to Integrate Multiple Comorbidities in Guideline Development: Article 10 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):274-281.
- National Institute for Health and Clinical Excellence. Positively Equal: A guide to addressing equality issues in developing clinical guidelines. 2012;http://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-guidelines/Clinical-guidelines/Positively-Equal.pdf. Accessed July 5, 2013.
- Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development: 7. Deciding what evidence to include.Health Research Policy and Systems. 2006;4(1):19.
- Hofmann B. Toward a procedure for integrating moral issues in health technology assessment.Int J Technol Assess Health Care. Summer 2005;21(3):312-318.
- Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development: 8. Synthesis and presentation of evidence.Health Research Policy and Systems. 2006;4(1):20.
- Guyatt G, Akl EA, Oxman A, et al. Synthesis, Grading, and Presentation of Evidence in Guidelines: Article 7 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):256-261.
- Edejer T. Improving the use of research evidence in guideline development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications.Health Research Policy and Systems. 2006;4(1):23.
- Schunemann H, Fretheim A, Oxman A. Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation.Health Research Policy and Systems. 2006;4(1):25.
- Hill SR, Olson LG, Falck-Ytter Y, et al. Incorporating Considerations of Cost-Effectiveness, Affordability, and Resource Implications in Guideline Development: Article 6 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):251-255.
- Schunemann H, Fretheim A, Oxman A. Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations.Health Research Policy and Systems. 2006;4(1):21.
- Wilson KC, Irwin RS, File TM, Schunemann HJ, Guyatt GH, Rabe KF. Reporting and Publishing Guidelines: Article 12 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):293-297.
- Schunemann HJ, Oxman AD, Akl EA, et al. Moving from Evidence to Developing Recommendations in Guidelines: Article 11 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):282-292.
- Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development: 16. Evaluation.Health Research Policy and Systems. 2006;4(1):28.
- Fretheim A, Schunemann H, Oxman A. Improving the use of research evidence in guideline development: 15. Disseminating and implementing guidelines.Health Research Policy and Systems. 2006;4(1):27.
- Grimshaw JM, Schunemann HJ, Burgers J, et al. Disseminating and Implementing Guidelines: Article 13 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.Proceedings of the American Thoracic Society. 2012;9(5):298-303.
- Cancer Care Ontario. Program in Evidence-Based Care Document Assessment and Review Protocol. 2012;http://www.cancercare.on.ca/about/programs/pebc/document__review/. Accessed April 22, 2013.